发明名称 Compound having anti-HCV activity and process for producing the same
摘要 The object of the present invention is to provide a compound useful for the prevention and treatment of viral infectious diseases, and particularly liver diseases caused by HCV infection due to its having a high degree of replication inhibitory activity against HCV, its production method, an intermediate compound useful for its production and a pharmaceutical composition containing these compounds, and the present invention relates to a compound represented by the formula (I): (wherein A represents -(CH<SUB>2</SUB>)<SUB>n</SUB>-, etc.; B represents -(C-O)-, etc.; D represents -(CH<SUB>2</SUB>)<SUB>m</SUB>-R', etc.; E represents a hydrogen atom, etc.; G represents -(CH<SUB>2</SUB>)<SUB>p</SUB>-J, etc.; bond Q represents a single bond or double bond; and R<SUB>1</SUB>, R<SUB>2 </SUB>and R<SUB>3 </SUB>may be the same or different and each represent a hydrogen atom, etc.), a prodrug thereof or a pharmaceutically acceptable salt thereof.
申请公布号 US7378446(B2) 申请公布日期 2008.05.27
申请号 US20050563089 申请日期 2005.12.30
申请人 CHUGAI SEIYAKU KABUSHIKI KAISHA 发明人 SUDOH MASAYUKI;TSUKUDA TAKUO;MASUBUCHI MIYAKO;KAWASAKI KENICHI;MURATA TAKESHI;WATANABE FUMIO;FUKUDA HIROSHI;KOMIYAMA SUSUMU;HAYASE TADAKATSU
分类号 A61K31/194;A61K31/195;A61K31/216;A61K31/381;A61K31/405;A61K31/4192;A61K31/4406;A61K31/4412;A61K31/45;A61K31/495;A61K31/505;A61K31/513;A61K31/5375;A61P31/12;C07C229/36;C07C235/76;C07C247/16;C07D211/46;C07D213/38;C07D213/46;C07D213/64;C07D213/65;C07D239/26;C07D241/04;C07D249/06;C07D265/30;C07D333/20 主分类号 A61K31/194
代理机构 代理人
主权项
地址